| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.3B | $9.6B | $9.4B | $8.6B | $8.5B | $2.1B | $1.8B | — |
| Cost of Revenue | $7.1B | $6.7B | $6.4B | $5.9B | $5.7B | $5.7B | $5.4B | — |
| Gross Profit | — | — | — | — | — | $0.7B | $0.6B | $0.6B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.1B | $1.0B | $1.3B | $1.2B | $1.5B | $1.1B | $1.0B | $0.5B |
| Net Income | $0.6B | $0.6B | $0.9B | $0.8B | $1.0B | $0.1B | $-0.0B | $0.1B |
| EPS (Basic) | $2.02 | $1.90 | $2.87 | $2.51 | $3.31 | $0.28 | $-0.03 | $0.31 |
| EPS (Diluted) | $2.01 | $1.89 | $2.85 | $2.51 | $3.29 | $0.28 | $-0.03 | $0.31 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $14.9B | $15.2B | $12.1B | $11.9B | $11.7B | $12.4B | $13.1B | $14.5B |
| Current Assets | $2.2B | $2.2B | $2.1B | $2.0B | $1.7B | $2.4B | $2.0B | $2.3B |
| Cash & Equivalents | $0.1B | $0.1B | $0.2B | $0.1B | $0.1B | $0.9B | $0.0B | $0.2B |
| Total Liabilities | $11.0B | $11.4B | $8.4B | $8.6B | $8.6B | $9.8B | $12.0B | $13.2B |
| Current Liabilities | $2.9B | $3.6B | $2.2B | $2.9B | $1.8B | $3.1B | $3.4B | $3.6B |
| Stockholders' Equity | $3.9B | $3.8B | $3.7B | $3.3B | $3.2B | $2.6B | $1.1B | $1.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $1.2B | $1.1B | $1.2B | $1.0B | $1.4B | $1.4B | $1.3B |
| Investing Cash Flow | $-0.2B | $-3.1B | $-0.3B | $-0.2B | $-0.2B | $2.3B | $0.2B | $-7.2B |
| Capital Expenditures | $0.4B | $0.5B | $0.4B | $0.2B | $0.3B | $0.3B | $0.4B | $0.4B |
| Financing Cash Flow | $-0.9B | $1.9B | $-0.7B | $-0.9B | $-1.7B | $-3.0B | $-1.6B | $5.8B |